Please login to the form below

Not currently logged in
Email:
Password:

Senior appointments at Glide Pharma

New chief financial officer and director of business development

Richard BungayGlide Pharma has appointed a chief financial officer and a director of business development as it prepares to scale up its commercial efforts.

Richard Bungay joins as chief financial officer from Verona, where he had served since September last year. Prior to this he was CEO of fellow UK biotech Chroma Therapeutics having previously been the company's chief financial officer.

His other previous include director of corporate communications and strategic planning at Celltech and finance director within the respiratory and inflammation therapy area at AstraZeneca.

New director of business development Tony Mills joins Glide from Q Chip where he was chief commercial officer.

Dr Mark Carnegie-Brown, Glide's CEO, commented: “Both are seasoned industry professionals, and attracting executives of their calibre is a testament to the progress Glide has made since completing a strategic fundraising last year for the scale-up of our device and formulation capabilities.”

9th July 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics